Crossmark

Survival risk prediction model for patients with pT1–3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes

Crossref DOI link: https://doi.org/10.1186/s13019-021-01503-0

Published Online: 2021-05-01

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qi, Zhan

Hu, Yuanping

Qiu, Rong

Li, Juan

Li, Yuekao

He, Ming

Wang, Yuxiang https://orcid.org/0000-0002-1049-8469
License Information

Text and Data Mining valid from 2021-05-01

Version of Record valid from 2021-05-01
More Information

Article History

Received: 28 October 2020

Accepted: 19 April 2021

First Online: 1 May 2021

Declarations

:

: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by Medical Ethics Committee of our hospital(2017MEC063), and written informed consent was obtained from all patients enrolled in this study.

: Written informed consent was obtained from all patients enrolled in this study.

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below